Literature DB >> 19652625

Asian ethnicity is a favorable prognostic factor for overall survival in non-small cell lung cancer (NSCLC) and is independent of smoking status.

Sai-Hong Ignatius Ou1, Argyrios Ziogas, Jason A Zell.   

Abstract

BACKGROUND: We previously showed that Asian ethnicity was an independent favorable prognostic factor in non-small cell lung cancer (NSCLC). Many Asian NSCLC patients were never-smokers, and never-smokers had improved survival than ever-smokers. We investigated whether Asian ethnicity is a favorable prognostic factor independent of smoking status.
METHODS: Retrospective population-based study of NSCLC cases from the cancer surveillance programs of three Southern California counties from 1991 to 2005.
RESULTS: A total of 20,140 NSCLC patients with known smoking status were analyzed of which 9.1% were never-smokers and 6.5% were Asians. There was a threefold increase in the percentage of Asian never-smokers as compared with ever-smokers. Asians had the highest overall survival (OS) among the 4 major ethnicities (p < 0.0001) and never-smokers had improved OS over ever-smokers (p = 0.0183) by univariate analyses. By multivariate analyses, Asian ethnicity was an independent and favorable prognostic factor for OS (versus non-Asian; hazard ratio [HR] = 0.861, 95% confidence interval [CI]: 0.808-0.918, p < 0.0001), among smokers (versus non-Asian; HR = 0.867, 95% CI: 0.807-0.931, p < 0.0001), and among never-smokers (versus non-Asian; HR = 0.841, 95% CI: 0.728-0.971, p = 0.0180). Never-smoker was a favorable prognostic factor if ethnicity was not accounted for (versus ever-smoker; HR = 0.936, 95% CI: 0.886-0.988, p = 0.0169) but was no longer an independent favorable prognostic factor (versus ever-smoker; HR = 0.953, 95% CI: 0.902-1.007, p = 0.0861) after accounting for ethnicity.
CONCLUSIONS: Asian ethnicity is an independent favorable prognostic factor for OS in NSCLC regardless of smoking status.

Entities:  

Mesh:

Year:  2009        PMID: 19652625     DOI: 10.1097/JTO.0b013e3181b27b15

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  39 in total

1.  Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis.

Authors:  Alice T Shaw; Beow Y Yeap; Benjamin J Solomon; Gregory J Riely; Justin Gainor; Jeffrey A Engelman; Geoffrey I Shapiro; Daniel B Costa; Sai-Hong I Ou; Mohit Butaney; Ravi Salgia; Robert G Maki; Marileila Varella-Garcia; Robert C Doebele; Yung-Jue Bang; Kimary Kulig; Paulina Selaru; Yiyun Tang; Keith D Wilner; Eunice L Kwak; Jeffrey W Clark; A John Iafrate; D Ross Camidge
Journal:  Lancet Oncol       Date:  2011-09-18       Impact factor: 41.316

2.  Differences in clinical presentation of non-small cell lung cancer in never-smokers versus smokers.

Authors:  Joo Young Lee; Im Ii Na; Seung-Hun Jang; Yong Il Hwang; Du Hwan Choe; Cheol Hyeon Kim; Heejong Baek
Journal:  J Thorac Dis       Date:  2013-12       Impact factor: 2.895

Review 3.  Prognostic role of ERCC1 in advanced non-small-cell lung cancer: a systematic review and meta-analysis.

Authors:  Joshua A Roth; Josh J Carlson
Journal:  Clin Lung Cancer       Date:  2011-07-01       Impact factor: 4.785

4.  Survival following non-small cell lung cancer among Asian/Pacific Islander, Latina, and Non-Hispanic white women who have never smoked.

Authors:  Scarlett L Gomez; Ellen T Chang; Sarah J Shema; Kari Fish; Jennette D Sison; Peggy Reynolds; Christelle Clément-Duchêne; Margaret R Wrensch; John L Wiencke; Heather A Wakelee
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-01-14       Impact factor: 4.254

5.  Survival following surgery with or without adjuvant chemotherapy for stage I-IIIA non-small cell lung cancer: an east asian population-based study.

Authors:  Zhong-Zhe Lin; Wen-Yi Shau; Yu-Yun Shao; Yen-Yun Yang; Raymond Nien-Chen Kuo; James Chih-Hsin Yang; Mei-Shu Lai
Journal:  Oncologist       Date:  2012-07-23

6.  Clinical characteristics of Japanese lung cancer patients with human immunodeficiency virus infection.

Authors:  Yusuke Okuma; Naoki Yanagisawa; Yusuke Takagi; Yukio Hosomi; Akihiko Suganuma; Akifumi Imamura; Mari Iguchi; Tatsuru Okamura; Atsushi Ajisawa; Masahiko Shibuya
Journal:  Int J Clin Oncol       Date:  2011-09-16       Impact factor: 3.402

Review 7.  Current status of research and treatment for non-small cell lung cancer in never-smoking females.

Authors:  Shin Saito; Fernando Espinoza-Mercado; Hui Liu; Naohiro Sata; Xiaojiang Cui; Harmik J Soukiasian
Journal:  Cancer Biol Ther       Date:  2017-05-11       Impact factor: 4.742

8.  Effect of smoking on survival from non-small cell lung cancer: a retrospective Veterans' Affairs Central Cancer Registry (VACCR) cohort analysis.

Authors:  Vijaya Raj Bhatt; Rishi Batra; Peter T Silberstein; Fausto R Loberiza; Apar Kishor Ganti
Journal:  Med Oncol       Date:  2014-11-28       Impact factor: 3.064

9.  Survival among Never-Smokers with Lung Cancer in the Cancer Care Outcomes Research and Surveillance Study.

Authors:  Christelle Clément-Duchêne; Shannon Stock; Xiangyan Xu; Ellen T Chang; Scarlett Lin Gomez; Dee W West; Heather A Wakelee; Michael K Gould
Journal:  Ann Am Thorac Soc       Date:  2016-01

Review 10.  Worldwide trend of increasing primary adenocarcinoma of the lung.

Authors:  Haruhiko Nakamura; Hisashi Saji
Journal:  Surg Today       Date:  2013-06-11       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.